featured
Rituximab Treatment for New-Onset Generalized Myasthenia Gravis vs Refractory Generalized Myasthenia Gravis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis
JAMA Neurol 2020 Aug 01;77(8)974-981, S Brauner, A Eriksson-Dufva, MA Hietala, T Frisell, R Press, F PiehlFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.